International Flavors & Fragrances Inc IFF
We take great care to ensure that the data presented and summarized in this overview for INTERNATIONAL FLAVORS & FRAGRANCES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding IFF
View all-
Vanguard Group Inc Valley Forge, PA30.1MShares$2.55 Billion0.06% of portfolio
-
Dodge & Cox San Francisco, CA28.1MShares$2.38 Billion1.78% of portfolio
-
Winder Investment Pte LTD25.4MShares$2.15 Billion81.82% of portfolio
-
Winder Pte. Ltd. Singapore, U025.4MShares$2.15 Billion84.02% of portfolio
-
Black Rock Inc. New York, NY21.5MShares$1.82 Billion0.05% of portfolio
-
State Street Corp Boston, MA10.5MShares$888 Million0.05% of portfolio
-
Geode Capital Management, LLC Boston, MA6.01MShares$509 Million0.05% of portfolio
-
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Frankfurt Am Main, 2M5MShares$424 Million0.55% of portfolio
-
Massachusetts Financial Services CO Boston, MA4.65MShares$395 Million0.15% of portfolio
-
Nordea Investment Management Ab Stockholm, V74.37MShares$370 Million0.53% of portfolio
Latest Institutional Activity in IFF
Top Purchases
Top Sells
About IFF
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
Insider Transactions at IFF
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 02
2024
|
Ralf Finzel EVP, Global Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,943
-20.19%
|
$176,813
$91.27 P/Share
|
Dec 02
2024
|
Ralf Finzel EVP, Global Operations Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,387
+35.89%
|
-
|
Nov 11
2024
|
Yuvraj Arora President, Nourish |
SELL
Open market or private sale
|
Direct |
5,000
-60.69%
|
$455,000
$91.75 P/Share
|
Oct 03
2024
|
Beril Yildiz CAO, SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-16.74%
|
$38,900
$100.63 P/Share
|
Oct 03
2024
|
Beril Yildiz CAO, SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,078
+31.69%
|
-
|
Oct 01
2024
|
Glenn R Richter CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,122
-15.92%
|
$527,566
$103.12 P/Share
|
Oct 01
2024
|
Glenn R Richter CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,812
+26.86%
|
-
|
Sep 03
2024
|
Deborah Borg EVP, Chief HR and D&I Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,049
-12.03%
|
$726,047
$103.58 P/Share
|
Sep 03
2024
|
Deborah Borg EVP, Chief HR and D&I Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,807
+18.1%
|
-
|
Jul 03
2024
|
Simon Herriott Pres. Health & Bioscience |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-2.69%
|
$27,455
$95.02 P/Share
|
Jul 03
2024
|
Simon Herriott Pres. Health & Bioscience |
BUY
Exercise of conversion of derivative security
|
Direct |
627
+5.51%
|
-
|
Jun 13
2024
|
Angela Strzelecki President, Pharma Solutions |
SELL
Open market or private sale
|
Direct |
2,588
-23.26%
|
$245,860
$95.66 P/Share
|
Jun 13
2024
|
Angela Strzelecki President, Pharma Solutions |
BUY
Exercise of conversion of derivative security
|
Direct |
2,588
+18.87%
|
$199,276
$77.16 P/Share
|
May 06
2024
|
De Mendonca Ana Paula Teles President, Scent |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-22.24%
|
$23,056
$88.66 P/Share
|
May 06
2024
|
De Mendonca Ana Paula Teles President, Scent |
BUY
Exercise of conversion of derivative security
|
Direct |
726
+38.13%
|
-
|
May 03
2024
|
Gaoxiang Hu Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,671
+44.25%
|
-
|
May 03
2024
|
Jennifer Amy Johnson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
765
-9.64%
|
$65,790
$86.64 P/Share
|
May 03
2024
|
Jennifer Amy Johnson EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,121
+21.09%
|
-
|
May 03
2024
|
Glenn R Richter CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,530
-6.99%
|
$131,580
$86.64 P/Share
|
May 03
2024
|
Glenn R Richter CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,243
+16.24%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 81.7K shares |
---|---|
Grant, award, or other acquisition | 710 shares |
Payment of exercise price or tax liability | 26.3K shares |
---|---|
Open market or private sale | 7.59K shares |